Over the last several decades, the Food and Drug Administration has allowed pharma companies to sell hundreds of drugs to patients without adequate evidence that they work and, in many cases, with clear signs that they pose a risk of serious harm.

  • ClockworkOtter@lemmy.world
    link
    fedilink
    English
    arrow-up
    5
    ·
    2 days ago

    Yes, though if the sponsor is doing it on the cheap then they might pick facilities and monitors who don’t care or don’t have the capacity to pick up on all the details, or scrutinise minutiae. The monitor can only QC what’s written down for example, and an investigator can be perfectly capable of having the bare minimum of a consent process and copy pasta as if it was done thoroughly.

    I’m glad all my participants are of sound mind; the idea of navigating the world of incapacity and research gives me the heebie jeebies.